Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)
Adler AI, Coleman RL, Leal J, Whiteley WN, Clarke P, Holman RR.
Lancet 2024; 404: 145-155. doi: 10.1016/S0140-6736(24)00537-3.2024